29.04.2015 • NewsDede WillamsSanofidrug approval

EU Approves Sales of Sanofi’s New Diabetes Drug

The European Commission has granted marketing authorization in Europe for Sanofi's Toujeo, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus in adults.

The Commission said its decision was based on results from the Edition clinical trial program, a series of worldwide Phase III studies evaluating the efficacy and safety of Toujeo compared with Lantus, another Sanofi product, in more than 3,500 adults with type 1 or type 2 diabetes.

Pierre Chancel, senior vice president, Global Diabetes, at Sanofi, said EU marketing authorization for Toujeo represents a "significant milestone" for the company, expanding its integrated portfolio of solutions for people with diabetes in Europe."

The marketing approval follows the Feb. 26 positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

Toujeo also has been approved by the US Food and Drug Administration (FDA) and is under review by regulatory authorities in other countries.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.